Pulmatrix (NASDAQ:PULM) Shares Cross Above 50 Day Moving Average – Should You Sell?

Pulmatrix, Inc. (NASDAQ:PULM)’s share price crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $7.44 and traded as high as $7.80. Pulmatrix shares last traded at $7.50, with a volume of 7,163 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on shares of Pulmatrix in a research report on Sunday, January 5th. They set a “hold” rating on the stock.

Pulmatrix Price Performance

The firm has a market capitalization of $27.27 million, a P/E ratio of -2.83 and a beta of 1.66. The company’s 50-day simple moving average is $7.47 and its two-hundred day simple moving average is $5.17.

Pulmatrix (NASDAQ:PULM) last released its quarterly earnings results on Friday, March 21st. The biotechnology company reported ($0.54) earnings per share for the quarter. Pulmatrix had a negative return on equity of 45.97% and a negative net margin of 96.51%.

Institutional Trading of Pulmatrix

An institutional investor recently bought a new position in Pulmatrix stock. SBI Securities Co. Ltd. bought a new position in Pulmatrix, Inc. (NASDAQ:PULM) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 66,188 shares of the biotechnology company’s stock, valued at approximately $462,000. SBI Securities Co. Ltd. owned about 1.81% of Pulmatrix at the end of the most recent quarter. 11.84% of the stock is currently owned by institutional investors.

About Pulmatrix

Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.